BENDAMUSTINE IN HEAVILY TREATED HODGKIN LYMPHOMA, A RETROSPECTIVE FRENCH STUDY IN 28 PATIENTS

被引：0
|
作者：
Brice, P. [1 ]
Ghesquieres, H. [2 ]
Stamatoullas, A. [3 ]
Casanovas, O. [4 ]
Morschhauser, F. [5 ]
Gyan, E. [6 ]
Gabarre, J. [7 ]
Malphettes, M. [1 ]
Clement, L. [8 ]
机构：
[1] Hop St Louis, Paris, France
[2] Ctr Leon Berard, Lyon, France
[3] Ctr Henri Becquerel, Rouen, France
[4] CHU Bocage, Dijon, France
[5] CHU Lille, Lille, France
[6] CHU Bretonneau, Tours, France
[7] Hop Pitie, Paris, France
[8] CHU Brabois, Nancy, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0214
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [41] Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
    Huang, Jen-Pei
    Yeh, Chiu-Mei
    Gong, Ya-Wen
    Tsai, Ming-Hsuan
    Lin, Yi-Tsung
    Tsai, Chun-Kuang
    Liu, Chia-Jen
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 4099 - 4109
  • [42] Managing Patients With Indolent Lymphoma Treated With Bendamustine: A Nursing Perspective
    Sorensen, Elizabeth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (03) : 303 - 311
  • [43] Vinorelbine (Navelbine) an active agent in the salvage of heavily pre-treated patients with Hodgkin's and non-Hodgkin's lymphoma
    Rule, S
    Tighe, M
    Johnson, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1402 - 1402
  • [44] Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients
    Musto, Pellegrino
    Fraticelli, Vincenzo Ludovico
    Mansueto, Giovanna
    D'Arena, Giovanni
    Petrilli, Maria Pia
    Gasbarrino, Cristiana
    Farina, Giuliana
    Guariglia, Roberto
    Martorelli, Maria Carmen
    Villani, Oreste
    Pietrantuono, Giuseppe
    Catalano, Lucio
    Madonna, Emanuela
    Nozza, Andrea
    Andriani, Alessandro
    Montefusco, Vittorio
    Mussetti, Alberto
    Lipari, Maria Grazia
    Ballanti, Stelvio
    Bongarzoni, Velia
    Tamiazzo, Stefania
    Patriarca, Francesca
    Vincelli, Donatella
    Falcone, Antonietta
    Derudas, Daniele
    Califano, Catello
    Zambello, Renato
    Mele, Giuseppe
    Fragasso, Alberto
    Baldini, Luca
    Palumbo, Antonio
    Storti, Sergio
    BLOOD, 2012, 120 (21)
  • [45] The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients
    Ghesquieres, Herve
    Krzisch, Daphne
    Nicolas-Virelizier, Emmanuelle
    Kanoun, Salim
    Gac, Anne Claire
    Guidez, Stephanie
    Touati, Mohamed
    Laribi, Kamel
    Morschhauser, Franck
    Bonnet, Christophe
    Waultier-Rascalou, Agathe
    Orsini-Piocelle, Frederique
    Andre, Marc
    Fournier, Marguerite
    Morand, Fabienne
    Berriolo-Riedinger, Alina
    Burroni, Barbara
    Damotte, Diane
    Traverse-Glehen, Alexandra
    Quittet, Philippe
    Casasnovas, Olivier
    BLOOD, 2024, 143 (11) : 983 - 995
  • [46] LONG-TERM RISK IN THE ERA OF MODERN THERAPY FOR HODGKIN LYMPHOMA. RETROSPECTIVE STUDY IN 295 HODGKIN'S LYMPHOMA PATIENTS TREATED FROM 2008 TO 2011
    Puccini, B.
    Landi, F.
    Mannelli, L.
    Simontacchi, G.
    Kovalchuk, S.
    Benelli, G.
    Bosi, A.
    Rigacci, L.
    HAEMATOLOGICA, 2017, 102 : 104 - 104
  • [47] DESCRIPTIVE STUDY OF THE INCIDENCE OF NEOPLASMS AFTER TREATMENT WITH BENDAMUSTINE IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA
    Gomez Toboso, D.
    Valero, M.
    Marti de Talavera J
    Tejada, C.
    Lopez, A.
    Lorente, P.
    Panero, M.
    Benet, C.
    Herrera, E.
    Mas, C.
    Carrera Ma, D.
    Sancho-Tello, R.
    Lopez Chulia, F.
    HAEMATOLOGICA, 2018, 103 : 284 - 284
  • [48] Pharmacokinetics and Safety of Bendamustine in the BEABOVP Regimen for the Treatment of Pediatric Patients With Hodgkin Lymphoma
    Purvis, Katelyn
    Swanson, Hope
    Niloy, Kumar
    Zhou, Yiwang
    Panetta, John
    Crews, Kristine
    Flerlage, Jamie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S407 - S408
  • [49] Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma
    Forlenza, Christopher J.
    Gulati, Nitya
    Mauguen, Audrey
    Absalon, Michael J.
    Castellino, Sharon M.
    Franklin, Anna
    Keller, Frank G.
    Shukla, Neerav
    BLOOD ADVANCES, 2021, 5 (24) : 5519 - 5524
  • [50] Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma
    Katelyn N. Purvis
    Hope D. Swanson
    Kumar Kulldeep Niloy
    Yiwang Zhou
    John C. Panetta
    Kristine R. Crews
    Jamie E. Flerlage
    Cancer Chemotherapy and Pharmacology, 2023, 92 : 1 - 6
12345